Aventyn, Inc.
6
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Role: lead
Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements
Role: lead
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
Role: lead
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
Role: lead
Assess Measurements of Wireless Cardiac Output Device
Role: lead
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
Role: lead
All 6 trials loaded